Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
September 05, 2024
12:00 PM - 01:00 PM EDT
Treatment Options for Ruxolitinib Intolerance or Resistance in Myelofibrosis
Treatment Options for Ruxolitinib Intolerance or Resistance in Myelofibrosis
Exploring Autophagy through Sigma-1 Receptor Activation: Innovative Therapeutics for Alzheimer's Disease Beyond Amyloid Pathways
Exploring Autophagy through Sigma-1 Receptor Activation: Innovative Therapeutics for Alzheimer's Disease Beyond Amyloid Pathways
Case Discussion: What JAK Inhibitor Should I Use in a Transfusion-Dependent Patient With MF With Platelets > 50 × 109/L?
Case Discussion: What JAK Inhibitor Should I Use in a Transfusion-Dependent Patient With MF With Platelets > 50 × 109/L?
Managing Treatment-Related Toxicities With JAK Inhibitor Therapy in Myelofibrosis
Managing Treatment-Related Toxicities With JAK Inhibitor Therapy in Myelofibrosis
How to Use Prognostic Risk Scoring and Symptom Burden Assessment to Tailor Myelofibrosis Treatment
How to Use Prognostic Risk Scoring and Symptom Burden Assessment to Tailor Myelofibrosis Treatment
Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer
Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer
Managing Myelofibrosis-Associated Thrombocytopenia
Managing Myelofibrosis-Associated Thrombocytopenia
Improving Transfusion Independence With JAK Inhibitor Therapy
Improving Transfusion Independence With JAK Inhibitor Therapy
Pacritinib for Myelofibrosis Across the Cytopenic Spectrum
Pacritinib for Myelofibrosis Across the Cytopenic Spectrum
Recommendations on the management of HCM in guidelines: European vs. American views
Recommendations on the management of HCM in guidelines: European vs. American views
Myosin inhibitors: recent clinical data and applications in HCM and HF
Myosin inhibitors: recent clinical data and applications in HCM and HF